[CLSTR]
< Back to situations

[ORGANIZATION]

GSK

Featured in 42 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [ES] [DO]

Cardiovascular risks in lupus patients

2 clusters · 5 sources · last updated

Latest: Medical experts highlight cardiovascular risks linked to obesity and lupus

Medical research and specialists have highlighted that patients with systemic lupus erythematosus (SLE) face approximately double the risk of cardiovascular diseases, such as heart attacks or strokes, compared to the gen

[ACTIVE] [HEALTH] [US]

FDA approval of GSK Hibsago for hepatitis B

2 clusters · 18 sources · last updated

Latest: FDA approves GSK drug Hibsago for chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), an injectable antisense oligonucleotide developed by GSK, for treating chronic hepatitis B in certain adults. This represents the first FDA

[ACTIVE] [BUSINESS] [CN] [US]

GSK oncology growth and strategic expansion

2 clusters · 4 sources · last updated

Latest: GSK and HUTCHMED sign cancer therapy licensing deal

GSK has outlined a long-term growth strategy aiming for sales exceeding £40 billion, driven largely by its oncology portfolio. To support this target and offset upcoming patent expirations for HIV medicines, the company

[ACTIVE] [BUSINESS] [ES]

Energy transition in Cuenca healthcare facilities

2 clusters · 6 sources · last updated

Latest: Hospital de Cuenca to install solar canopies for energy self-consumption

The Castilla-La Mancha Health Service (SESCAM) is implementing various decarbonization and energy transition initiatives across healthcare facilities in Cuenca, Spain. Initially, the Integrated Care Management of Cuenca

[QUIET] [HEALTH] [GR] [IT] [US]

Multiple myeloma treatment regulatory approvals

2 clusters · 16 sources · last updated

Latest: AIFA approves belantamab mafodotin for multiple myeloma in Italy

Regulatory authorities have granted approvals for new multiple myeloma treatments in the United States and Italy. In September 2026, the US Food and Drug Administration (FDA) issued accelerated approval for iberdomide.

[QUIET] [BUSINESS] [BE]

Economic and industrial challenges in Belgium

2 clusters · 4 sources · last updated

Latest: Belgium Minister warns of industrial decline in Europe

Belgium is experiencing various economic and financial pressures. Research indicates a shift in public concern, where geopolitical instability has overtaken inflation as the primary financial worry for approximately 30.8

[QUIET] [BUSINESS] [BE] [CR]

GSK global corporate restructuring

2 clusters · 8 sources · last updated

Latest: GSK announces 1,217 job cuts across Belgian sites

Pharmaceutical multinational GSK has initiated a global restructuring and transformation strategy to optimize internal functions and increase efficiency. In Costa Rica, the company communicated a corporate realignment t

[QUIET] [HEALTH] [US]

Viola Davis shingles awareness campaign

3 clusters · 5 sources · last updated

Latest: Viola Davis partners with GSK to raise shingles awareness

Actress Viola Davis has publicly shared her personal experiences with herpes zoster, commonly known as shingles, to raise awareness about the condition. Davis described the physical impact of the virus, noting that the n

[QUIET] [HEALTH] [US] [GB] [AU]

Shingles trends and Shingrix vaccine research

8 clusters · 38 sources · last updated

Latest: Shingles vaccine demand rises amid potential dementia prevention links

Recent data indicates a significant rise in shingles cases among younger adults, particularly millennial women in the United States and the United Kingdom. Research shows that cases among adults aged 30–49 in the U.S. mo

[QUIET] [HEALTH] [IT] [AR] [AU]

Meningitis awareness and vaccination gaps in Italy

2 clusters · 11 sources · last updated

Latest: Italian pediatricians warn 1.8 million children lack meningococcal B protection

A global survey involving several countries, including Italy, has identified a significant gap between public knowledge and the perceived risk of meningitis. In Italy, findings indicate that while awareness of the diseas

[QUIET] [HEALTH] [ES]

Global meningitis awareness and prevention efforts

2 clusters · 7 sources · last updated

Latest: World Meningitis Day awareness efforts focus on prevention and vaccination

World Meningitis Day, observed on October 5, serves as a global platform to increase awareness of meningitis, an infectious disease causing inflammation of the brain and spinal cord membranes. The disease can be caused b

[QUIET] [HEALTH] [IT] [BE] [IE]

Depemokimab approval and clinical use in Europe

2 clusters · 21 sources · last updated

Latest: European Commission approves depemokimab for severe asthma

Medical experts initially highlighted the efficacy of depemokimab, a monoclonal antibody targeting interleukin 5 (IL-5), for treating severe eosinophilic asthma and nasal polyposis. During the European Respiratory Societ

[QUIET] [HEALTH] [BR]

Brazil HIV prevention technology incorporation

4 clusters · 16 sources · last updated

Latest: Brazil evaluates adding weight loss drugs and injectable HIV prevention to SUS

Brazil’s National Commission for the Incorporation of Technologies in the SUS (Conitec) has issued a preliminary favorable recommendation to include injectable cabotegravir in the Unified Health System (SUS). This long-a

Also covered in